# Larry A. Allen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/larry-a-allen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,105 |
| Field | Heart Failure Treatment and Management |
| h-index | 80 |
| i10-index | 258 |
| Last Known Institution | University of Colorado Anschutz Medical Campus |
| OpenAlex ID | https://openalex.org/A5087791202 |
| ORCID iD | https://orcid.org/0000-0003-2540-3095 |
| Works | 598 |

## Researcher papers

Showing 12 of 13.

- [Forecasting the Impact of Heart Failure in the United States](https://scholariq.org/papers/forecasting-the-impact-of-heart-failure-in-the-united-states/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/)
- [Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure](https://scholariq.org/papers/red-cell-distribution-width-as-a-novel-prognostic-marker-in-heart-failure/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive/)
- [Decision Making in Advanced Heart Failure](https://scholariq.org/papers/decision-making-in-advanced-heart-failure/)
- [Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update](https://scholariq.org/papers/type-2-diabetes-mellitus-and-heart-failure-a-scientific-statement-from-the/)
- [Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association](https://scholariq.org/papers/atrial-fibrillation-burden-moving-beyond-atrial-fibrillation-as-a-binary-entity/)
- [Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-effects-on-biomarkers-symptoms-and-functional-status-in-patients/)
- [Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure](https://scholariq.org/papers/association-of-the-hospital-readmissions-reduction-program-implementation-with/)
- [2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-acc-aha-hfsa-guideline-for-the-management-of-heart-failure/)
- [Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure](https://scholariq.org/papers/validation-and-potential-mechanisms-of-red-cell-distribution-width-as-a/)
- [Danon Disease](https://scholariq.org/papers/danon-disease/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Cardiac Arrest and Resuscitation](https://scholariq.org/topics/cardiac-arrest-and-resuscitation/)

## Researcher university

- [University of Colorado Anschutz Medical Campus](https://scholariq.org/institutions/university-of-colorado-anschutz-medical-campus/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.